Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zanthoxylum clava-herculis bark is a plant-derived herbal product traditionally used in North American medicine for a variety of ailments including coughs, fevers, poor circulation, digestive issues, rheumatism, and toothache. The bark contains active compounds such as alkaloids (notably chelerythrine and magnoflorine), coumarins, lignans, volatile oils (including xanthoxylin), resins, and tannins. These constituents are believed to contribute to its medicinal effects. Mechanistically, extracts from the bark have demonstrated neuromuscular effects—either stimulating or inhibiting muscle contractile response via actions on postjunctional end-plate receptors or neurotransmitter release—and hypotensive activity in animal studies. The alkaloid chelerythrine has shown antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Magnoflorine may inhibit NF-kB-mediated inflammation and promote vasodilation and microcirculation. Zanthoxylum clava-herculis is not an approved pharmaceutical drug but is available as an ingredient in some over-the-counter herbal products[2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zanthoxylum clava-herculis bark.